Jill Wechsler
Jill Wechsler
Washington editor
Washington Report
jwechsler@advanstar.com
Jill Wechsler is a veteran Washington reporter specializing in government policies that affect biomedical research and development and health care delivery in the US and abroad. She regularly writes about the Food and Drug Administration, Congress and federal and state policies as Washington editor of Pharmaceutical Executive, Pharmaceutical Technology, Applied Clinical Trials, BioPharm International and Managed Healthcare Executive magazines - all published by Advanstar Communications. In her career as a writer and editor she has contributed to a number of national consumer and specialized publications including Money Magazine, The Washington Post, Working Woman, American Artist, Dun's Review, and Good Housekeeping.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
